Aytu BioPharma Inc (AYTU)
2.94
-0.02
(-0.68%)
USD |
NASDAQ |
May 17, 16:00
2.95
+0.01
(+0.34%)
After-Hours: 20:00
Aytu BioPharma Total Assets (Quarterly): 131.25M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 131.25M |
| September 30, 2023 | 132.89M |
| June 30, 2023 | 136.46M |
| March 31, 2023 | 147.22M |
| December 31, 2022 | 141.44M |
| September 30, 2022 | 150.00M |
| June 30, 2022 | 137.62M |
| March 31, 2022 | 168.83M |
| December 31, 2021 | 223.82M |
| September 30, 2021 | 227.73M |
| June 30, 2021 | 265.67M |
| March 31, 2021 | 271.56M |
| December 31, 2020 | 166.74M |
| September 30, 2020 | 141.27M |
| June 30, 2020 | 153.29M |
| March 31, 2020 | 158.95M |
| December 31, 2019 | 74.48M |
| September 30, 2019 | 31.02M |
| June 30, 2019 | 34.72M |
| March 31, 2019 | 38.34M |
| December 31, 2018 | 42.40M |
| September 30, 2018 | 17.98M |
| June 30, 2018 | 21.06M |
| March 31, 2018 | 23.37M |
| December 31, 2017 | 18.86M |
| Date | Value |
|---|---|
| September 30, 2017 | 21.25M |
| June 30, 2017 | 15.00M |
| March 31, 2017 | 15.92M |
| December 31, 2016 | 21.51M |
| September 30, 2016 | 20.20M |
| June 30, 2016 | 24.34M |
| March 31, 2016 | 21.99M |
| December 31, 2015 | 24.41M |
| September 30, 2015 | 21.36M |
| June 30, 2015 | 18.19M |
| March 31, 2015 | 10.20M |
| February 28, 2015 | 0.008M |
| November 30, 2014 | 0.0112M |
| August 31, 2014 | 0.0055M |
| May 31, 2014 | 0.0135M |
| February 28, 2014 | 0.0056M |
| November 30, 2013 | 0.0072M |
| August 31, 2013 | 0.0097M |
| May 31, 2013 | 0.0094M |
| February 28, 2013 | 0.0131M |
| November 30, 2012 | 0.0119M |
| August 31, 2012 | 0.0126M |
| May 31, 2012 | 0.014M |
| February 29, 2012 | 0.0163M |
| November 30, 2011 | 0.0188M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
31.02M
Minimum
Sep 2019
271.56M
Maximum
Mar 2021
152.37M
Average
147.22M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Regen BioPharma Inc | 0.1408M |
| Clearday Inc | 10.20M |
| Bioxytran Inc | 0.1255M |
| Shuttle Pharmaceuticals Holdings Inc | 4.754M |
| CEL-SCI Corp | 30.05M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 98.40M |
| Shareholders Equity (Quarterly) | 32.85M |
| Debt to Equity Ratio | 0.4883 |
| Current Ratio | 1.112 |
| Net Debt Paydown Yield | 8.26% |